Federated Hermes
VBIV

Federated Hermes’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Federated Hermes’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,249
Closed -$279K – 2360
2020
Q3 		$279K Sell
3,249
-3,410
-51% -$397K ﹤0.01% 1609
2020
Q2 		$619K Buy
+6,659
New +$367K ﹤0.01% 1421

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Federated Hermes's VBIV Position: Q4 2020 in Review

Federated Hermes sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2020, closing a stake of 3,249 shares — an estimated $279K sold.

Federated Hermes first reported a position in VBIV in Q2 2020 and held it in 2 quarters. The position peaked at $619K in Q2 2020. 122 funds tracked by Wall St. Rank hold VBIV as of Q4 2020.

  • Federated Hermes reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2020 after selling out during the quarter.
  • Federated Hermes sold 3,249 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2020, an estimated $279K.
  • Federated Hermes first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2020 and held it in 2 quarters.
  • Federated Hermes's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $619K in Q2 2020.
  • 122 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2020.

Based on Federated Hermes's 13F filing for Q4 2020, filed 12 Feb 2021.